Resistant Cancer
📧 Sign up to get email alerts when something new happens for Resistant Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-03-10Clinical Trial Update: Lorlatinib Combinations in Lung Cancer [Phase 1, Phase 2]
Phase 1/2 trial exploring lorlatinib combinations in lung cancer with ALK translocations and related resistant/metabolic alterations; status…